Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
Oxaliplatin-induced peripheral neuropathy (OXAIPN) is of great clinical interest as it ranks among the most common dose limiting toxicities of oxaliplatin (OXA) administration with an obvious impact on the outcome of cancer patients. In addition, OXAIPN has a detrimental effect on the quality of lif...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-05-01
|
Series: | Toxics |
Subjects: | |
Online Access: | http://www.mdpi.com/2305-6304/3/2/187 |